"Folate Receptor 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of GPI-anchored folate receptors that is expressed in tissues of epithelial origin. This protein is also identified as an ovarian-tumor-specific antigen.
Descriptor ID |
D058975
|
MeSH Number(s) |
D12.776.157.530.450.074.500.299.500.500 D12.776.395.550.448.370.500 D12.776.543.484.500.370.500 D12.776.543.550.418.370.500 D12.776.543.585.450.074.500.224.500.500 D12.776.543.750.301.500 D23.050.285.384
|
Concept/Terms |
Folate Receptor 1- Folate Receptor 1
- Receptor 1, Folate
- Ovarian Tumor-Associated Antigen MOv18
- Ovarian Tumor Associated Antigen MOv18
- Folate Receptor alpha
- Receptor alpha, Folate
|
Below are MeSH descriptors whose meaning is more general than "Folate Receptor 1".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Carrier Proteins [D12.776.157]
- Membrane Transport Proteins [D12.776.157.530]
- Ion Pumps [D12.776.157.530.450]
- Anion Transport Proteins [D12.776.157.530.450.074]
- Organic Anion Transporters [D12.776.157.530.450.074.500]
- Folic Acid Transporters [D12.776.157.530.450.074.500.299]
- Folate Receptors, GPI-Anchored [D12.776.157.530.450.074.500.299.500]
- Folate Receptor 1 [D12.776.157.530.450.074.500.299.500.500]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- GPI-Linked Proteins [D12.776.395.550.448]
- Folate Receptors, GPI-Anchored [D12.776.395.550.448.370]
- Folate Receptor 1 [D12.776.395.550.448.370.500]
- Membrane Proteins [D12.776.543]
- Lipid-Linked Proteins [D12.776.543.484]
- GPI-Linked Proteins [D12.776.543.484.500]
- Folate Receptors, GPI-Anchored [D12.776.543.484.500.370]
- Folate Receptor 1 [D12.776.543.484.500.370.500]
- Membrane Glycoproteins [D12.776.543.550]
- GPI-Linked Proteins [D12.776.543.550.418]
- Folate Receptors, GPI-Anchored [D12.776.543.550.418.370]
- Folate Receptor 1 [D12.776.543.550.418.370.500]
- Membrane Transport Proteins [D12.776.543.585]
- Ion Pumps [D12.776.543.585.450]
- Anion Transport Proteins [D12.776.543.585.450.074]
- Organic Anion Transporters [D12.776.543.585.450.074.500]
- Folic Acid Transporters [D12.776.543.585.450.074.500.224]
- Folate Receptors, GPI-Anchored [D12.776.543.585.450.074.500.224.500]
- Folate Receptor 1 [D12.776.543.585.450.074.500.224.500.500]
- Receptors, Cell Surface [D12.776.543.750]
- Folate Receptors, GPI-Anchored [D12.776.543.750.301]
- Folate Receptor 1 [D12.776.543.750.301.500]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Neoplasm [D23.050.285]
- Folate Receptor 1 [D23.050.285.384]
Below are MeSH descriptors whose meaning is more specific than "Folate Receptor 1".
This graph shows the total number of publications written about "Folate Receptor 1" by people in this website by year, and whether "Folate Receptor 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Folate Receptor 1" by people in Profiles.
-
Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer. Gynecol Oncol. 2018 10; 151(1):46-52.
-
Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment. Nanomedicine. 2018 02; 14(2):373-384.
-
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration. J Nanobiotechnology. 2016 Jun 21; 14(1):47.
-
Efficient delivery of gold nanoparticles by dual receptor targeting. Adv Mater. 2011 Nov 16; 23(43):5034-8.